Finding Parallels Between Cures and Life

The Real Causes Of Stargardt Disease And Its Possible Treatments Stargardt disease which is also known as juvenile macular degeneration and sometimes juvenile macular dystrophy is a disorder that usually affects persons between ages 6 years old and 20 years old. The disease causes blurry vision, appearance of black or grey spots in the patient’s central vision, light sensitivity, damage of central vision, excessive glare and part blindness to juveniles. The first time Stargardt disease symptoms were documented is in 1901 by Stargardt, the eye doctor. As per the available statistics, it is assumed that 1 in every 10,000 young people today suffer from this disease. Until recently, there was no treatment for this disease. Nevertheless, there has been some improvement and so far there is hope for better.
The Art of Mastering Resources
So what, therefore, causes Stargardt disease?
A Simple Plan: Options
Visual problems suffered by Stargardt disease patients are caused by macular degeneration. Macula is the center part of the retina which is crowded with light sensitive features. Therefore, macula is the part of eye that is in control of allowing humans to focus and achieve precision of sight every time they look forward. Based on research, it has been found out that juvenile macular degeneration causes unusual deposits underneath a special protective layer in the retina known as RPE. As the unusual deposits accumulate they subsequently lead to dysfunction of the RPE layer in retina. RPE layer is located somewhere between the retinal receptors and vascular layers. The function of RPE layer is to keep healthy light receptors and allow nutrients and energy to flow from blood vessels to the light receptors. However, when the unusual deposits start top form in the eye, this free flow of energy and nutrients is interrupted. The interruption of free flow will cause damage and dysfunction to light receptors which is responsible for loss of central vision. This disorder did not have any treatment, until recently. As a result of recent advancement in stem cell research, scientists are now capable of regenerating copious amounts of RPE layer cells. Additionally, it is now a reality that surgery can be conducted to graft RPE layer cells and replace dysfunctional cells that have been damaged by the unwanted deposits. Even so, the surgical replacement of RPE layer cells is still in trials in a number of clinics to ascertain whether it can provide a long lasting solution to successfully correct a patient’s central vision. Whereas that is the position thus far, stem based macular degeneration treatment is providing Stargardt disease patients with the much needed hope that has long been lacking even as late as a decade ago. It is recommended, however, that children suffering from juvenile macular degeneration should always be under regular care and supervision of an Ophthalmologist.